These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3857079)

  • 21. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
    Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
    J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU).
    Allieri MA; Douay L; Deloux J; Smadja N; Najman A; Gorin NC
    Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of proliferation and differentiation of acute myeloid leukemia cells on a bone marrow stroma in culture.
    Schölzel C; Löwenberg B
    Exp Hematol; 1985 Aug; 13(7):664-9. PubMed ID: 3861327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
    Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
    Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of the CFU-C assay in acute nonlymphocytic leukemia.
    Kirshner JJ; Goldberg J; Nelson DA; Gottlieb AJ
    Am J Med; 1982 Apr; 72(4):615-19. PubMed ID: 7041644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of minimal residual disease in acute myeloid leukemia.
    Gerhartz HH; Schmetzer H
    Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulopoietic progenitor cells (CFU-C) in patients with acute leukemia: a comparison of two different culture techniques.
    Gerhartz H; Jehn U
    Onkologie; 1985 Aug; 8(4):214-6. PubMed ID: 3912690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to therapy in acute myeloid leukaemia: an explanation of two unrelated findings.
    Francis GE
    Med Hypotheses; 1979 Sep; 5(9):999-1006. PubMed ID: 316495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth.
    Ohler L; Berer A; Aletaha D; Kabrna E; Heinze G; Streubel B; Fonatsch C; Haas OA; Lechner K; Geissler K
    Br J Haematol; 2001 Apr; 113(1):120-5. PubMed ID: 11328291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
    Kubota T; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognotic significance of pretreatment proliferative activity in adult acute leukemia.
    Hart JS; George SL; Frei E; Bodey GP; Nickerson RC; Freireich EJ
    Cancer; 1977 Apr; 39(4):1603-17. PubMed ID: 265746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of agar and liquid cultures in AML patients before treatment, early postinduction and in remission.
    Müller MR; Hofmann V; Koller A; Erni J
    Leuk Res; 1987; 11(1):17-23. PubMed ID: 3468314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
    Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
    Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marrow culture studies in adult acute leukemia at presentation and during remission.
    Vincent PC; Sutherland R; Bradley M; Lind D; Gunz FW
    Blood; 1977 Jun; 49(6):903-12. PubMed ID: 266408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.